VaxForm consulting envisions a world where formulation takes a leading role in providing solutions to development of vaccines against life threatening diseases.

Latest News
Group A Strep Vaccine

11Oct2016 - VaxForm has published the results of their non-clinical safety study for their vaccine targeting Streptococcus pyogenes.  The article citation is: Preclinical safety study of a recombinant Streptococcus pyogenes formulated...

View More
2016 AAPS Annual Meeting

Dr. Elodie Burlet will present a poster entitled "Evaluation of potency, correlates of protection, and stability of a novel Streptococcus pyogenes recombinant fusion protein." The presentation will occur on Monday, November 14th at...

View More